Lecithin
Imagent (lecithin) is a small molecule pharmaceutical. Lecithin was first approved as Imagent on 2002-05-31. It is used to treat mental fatigue in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| mental fatigue | — | D005222 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
170 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | — | 1 | 1 | 2 | — | 4 |
| Liver failure | D017093 | HP_0001399 | K72.9 | 1 | 1 | — | 1 | 1 | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | 1 | 2 | 3 |
| Alcoholic liver diseases | D008108 | EFO_0008573 | K70 | — | — | — | 1 | 1 | 2 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | 1 | 1 | 2 |
| Hepatitis b | D006509 | — | — | — | — | — | 1 | — | 1 |
| Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | — | — | — | 1 | — | 1 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | 1 | — | 1 |
| Spontaneous abortion | D000022 | EFO_1001255 | O00.1 | — | — | — | 1 | — | 1 |
| Habitual abortion | D000026 | EFO_1000954 | N96 | — | — | — | 1 | — | 1 |
Show 6 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | 3 | 4 | — | 1 | 7 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 2 | 2 | — | 3 | 6 |
| Covid-19 | D000086382 | — | U07.1 | — | 3 | 2 | — | — | 5 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | 1 | — | — | 1 |
| Panic disorder | D016584 | EFO_0004262 | F41.0 | — | — | 1 | — | — | 1 |
| Social phobia | D000072861 | EFO_1001917 | F40.1 | — | — | 1 | — | — | 1 |
| Agoraphobia | D000379 | EFO_1001872 | F40.0 | — | — | 1 | — | — | 1 |
| Parenteral nutrition | D010288 | — | — | — | 1 | 1 | — | — | 1 |
| Viral bronchiolitis | D001990 | — | — | — | — | 1 | — | — | 1 |
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | — | 1 | — | — | 1 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 3 | 1 | — | — | 6 | 10 |
| Acute kidney injury | D058186 | HP_0001919 | N17 | 2 | 1 | — | — | — | 3 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | 1 | — | — | 2 | 3 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | 2 | — | — | 1 | 3 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 2 | — | — | — | 2 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | 1 | — | — | — | 2 |
| Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 2 | — | — | — | 2 |
| Proteinuria | D011507 | HP_0000093 | R80 | — | 2 | — | — | — | 2 |
| Systemic inflammatory response syndrome | D018746 | EFO_1001478 | R65.10 | — | 1 | — | — | 1 | 2 |
| Hiv | D006678 | — | O98.7 | — | 1 | — | — | — | 1 |
Show 17 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | 4 | 5 |
| Child development | D002657 | — | — | 2 | — | — | — | — | 2 |
| Diet therapy | D004035 | — | — | 1 | — | — | — | — | 1 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
| Bronchopulmonary dysplasia | D001997 | — | P27.8 | 1 | — | — | — | — | 1 |
| Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 1 | — | — | — | — | 1 |
| Retinitis pigmentosa | D012174 | HP_0000580 | H35.52 | 1 | — | — | — | — | 1 |
| Leber congenital amaurosis | D057130 | Orphanet_65 | H35.5 | 1 | — | — | — | — | 1 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | — | — | 1 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | 1 | — | — | — | — | 1 |
Show 8 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dry eye syndromes | D015352 | — | H04.12 | — | — | — | — | 3 | 3 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 2 | 2 |
| Growth disorders | D006130 | — | — | — | — | — | — | 2 | 2 |
| Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | — | — | — | 2 | 2 |
| Premature birth | D047928 | EFO_0003917 | O60 | — | — | — | — | 2 | 2 |
| Metabolism | D008660 | GO_0008152 | — | — | — | — | — | 2 | 2 |
| Heart disease risk factors | D000082742 | — | — | — | — | — | — | 2 | 2 |
| Xerostomia | D014987 | — | K11.7 | — | — | — | — | 2 | 2 |
| Endotoxemia | D019446 | — | — | — | — | — | — | 1 | 1 |
| Sleep | D012890 | GO_0030431 | — | — | — | — | — | 1 | 1 |
Show 32 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Lecithin |
| INN | perflubron |
| Description | Lecithin (/ˈlÉ›sɪθɪn/ LESS-ith-in; from the Ancient Greek λÎκιθος lékithos "yolk") is a generic term to designate any group of yellow-brownish fatty substances occurring in animal and plant tissues which are amphiphilic – they attract both water and fatty substances (and so are both hydrophilic and lipophilic), and are used for smoothing food textures, emulsifying, homogenizing liquid mixtures, and repelling sticking materials.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | C[N+](C)(C)CCOP(=O)([O-])OCC(COC=O)OC=O |
Identifiers
| PDB | — |
| CAS-ID | 93685-90-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2107798 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | Q1D0Q7R4D9 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 31,662 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
90 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use